Skip to content
Screener

LeMaitre Vascular LMAT Retained Earnings

Retained Earnings at other companies

ITG
Integer HoldingsITGR
$1.01B+16.3%
Abbott logo
AbbottABT
$49.79B+2.7%
Baxter International logo
Baxter InternationalBAX
$13.69B-8.6%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$17.39B+7.7%
Artivion logo
ArtivionAORT
-$63.59M-5.2%
Edwards Lifesciences logo
Edwards LifesciencesEW
$14.62B+8.1%

Other financials

Income statement

See full
Revenue$70.4M+9.6%
Gross profit$50.8M+12.9%
Operating income$20.4M+26.4%
Net income$17.1M+23.7%
EPS (diluted)$0.74+23.3%

Balance sheet

See full
Cash & equivalents$26.6M-2.0%
Total debt$21.2M+19.7%
Total equity$420.3M+15.9%
Total assets$640.5M+10.9%

Cash flow

See full
Operating cash flow$16.0M-21.3%
CapEx$2.3M+72.4%
Free cash flow$13.7M-28.0%

Valuation

See full
Market cap$1.86B-11.2%
Enterprise value$1.86B-11.0%
P/E28.4×-16.1×
P/S7.1×-1.8×

Profitability

See full
Gross margin72.9%+3.8pp
Operating margin29.5%+6.1pp
Net margin25%+4.9pp
FCF margin28.1%+5.8pp

Returns & leverage

See full
Return on equity16.8%+3.0pp
Debt / equity0.1×0.0×
Current ratio16.3×+2.4×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 6:30 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333762
Line item(unaudited) / June 30, 2026December 31, 2025
Preferred stock, $0.01 par value; 3,000,000 shares authorized; none issued and outstanding
Common stock, $0.01 par value; 37,000,000 shares authorized, 24,494,202 and 24,396,904 shares issued, 22,864,935 and 22,772,607 shares outstanding, respectively245244
Additional paid-in capital236,161228,407
Retained earnings206,017184,715
Accumulated other comprehensive loss(4,165)(2,411)
Treasury stock, at cost; 1,629,267 and 1,624,297 shares, respectively(17,916)(17,439)
Total stockholders’ equity420,342393,516
Total liabilities and stockholders’ equity$640,549$615,690

Item 1. Financial Statements

FAQ

What is LeMaitre Vascular's retained earnings?
LeMaitre Vascular (LMAT) reported retained earnings of $206.02M in Q2 2026.
How has LeMaitre Vascular's retained earnings changed year-over-year?
LeMaitre Vascular's retained earnings increased by 28.1% year-over-year, from $160.84M to $206.02M.
What is the long-term trend for LeMaitre Vascular's retained earnings?
Over 5 years (2020 to 2025), LeMaitre Vascular's retained earnings has grown at a 21.2% compound annual growth rate (CAGR), from $70.55M to $184.72M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Ask your AI about LeMaitre Vascular's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude